Showing results (661-670 of 5,007) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|October 22, 1998
Biochemical modulation of 5-fluorouracil by methotrexate in patients with advanced gastric carcinomaJ E Pérez, J A Lacava, M E Dominguez, et al.
American Journal of Clinical Oncology|October 22, 1998
Gastric small-cell carcinoma in Japan: a case report and review of the literatureK Arai, M Matsuda
American Journal of Clinical Oncology|October 22, 1998
A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagusC F Slabber, J S Nel, L Schoeman, et al.
American Journal of Clinical Oncology|October 22, 1998
Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expressionA Singh, A Tong, N Ognoskie, et al.
American Journal of Clinical Oncology|October 22, 1998
Docetaxel in head and neck cancer: a reviewA D Colevas, M R Posner
American Journal of Clinical Oncology|October 22, 1998
Classic Kaposi sarcoma: experience at Rabin Medical Center in IsraelE Fenig, B Brenner, E Rakowsky, et al.
American Journal of Clinical Oncology|October 22, 1998
Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II studyF Rey, P Astoul, L Marqueste, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
American Journal of Clinical Oncology|October 22, 1998
Carcinoma of the pancreas presenting as an orbital tumor: a case reportN Geetha, B Chandralekha, A Kumar, et al.
American Journal of Clinical Oncology|December 18, 1998
Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancerG A Bjarnason, C Cripps, R Goel, et al.
Pageof 501